Company / Accounts Receivable
GT Biopharma, Inc. Accounts Receivable History
FY2013-FY2013 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Accounts Receivable
$40.0K
FY2013
5-year range
-
FY2013-FY2013
Trend
-
vs FY2012
Sector context
Sector data unavailable
Latest sector comparison
What the data says
$40,000 in FY2013.
Accounts Receivable over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Accounts ReceivableValue | YoY GrowthYoY |
|---|---|---|
| FY2020 | - | - |
| FY2017 | - | - |
| FY2016 | - | - |
| FY2015 | - | - |
| FY2014 | - | - |
| FY2013 | $40.0K | - |
| FY2012 | - | - |
| FY2011 | - | - |
As of FY2013 · SEC 10-K · Updated Jun 24, 2026